1. Home
  2. DAWN vs PLUS Comparison

DAWN vs PLUS Comparison

Compare DAWN & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo ePlus inc.

PLUS

ePlus inc.

HOLD

Current Price

$85.78

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAWN
PLUS
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
DAWN
PLUS
Price
$21.50
$85.78
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$24.43
N/A
AVG Volume (30 Days)
1.4M
132.3K
Earning Date
05-01-2026
05-21-2026
Dividend Yield
N/A
1.20%
EPS Growth
N/A
N/A
EPS
N/A
4.08
Revenue
$158,182,000.00
$2,068,789,000.00
Revenue This Year
$55.03
$19.83
Revenue Next Year
$28.12
$4.36
P/E Ratio
N/A
$21.02
Revenue Growth
20.60
N/A
52 Week Low
$5.64
$62.11
52 Week High
$21.53
$93.98

Technical Indicators

Market Signals
Indicator
DAWN
PLUS
Relative Strength Index (RSI) 80.29 65.43
Support Level $10.30 $85.63
Resistance Level N/A $89.78
Average True Range (ATR) 0.03 2.20
MACD -0.28 0.06
Stochastic Oscillator 90.91 86.83

Price Performance

Historical Comparison
DAWN
PLUS

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: